Richard Aguilar - Mar 15, 2022 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role: Chief Clinical Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Stock symbol: CANO
Transactions as of: Mar 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/17/2022, 06:57 PM
Previous filing: Jan 20, 2022
Next filing: Jan 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Award		+172K	+23.9%		890K	Mar 15, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CANO	Stock Option (Right to Buy)	Award	$0	+37.3K		$0.00	37.3K	Mar 15, 2022	Class A Common Stock	37.3K	$6.03	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31, 2022 and the remaining 50% of the RSUs vest on December, 31, 2023. The RSUs were granted on March 15, 2022.
F2	The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 15, 2023, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 15, 2022.